BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37030398)

  • 1. Preanalytic Methodological Considerations and Sample Quality Control of Circulating miRNAs.
    Chan SF; Cheng H; Goh KK; Zou R
    J Mol Diagn; 2023 Jul; 25(7):438-453. PubMed ID: 37030398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA profiles in blood plasma from mother-child duos in human biobanks and the implication of sample quality: Circulating miRNAs as potential early markers of child health.
    Dypås LB; Gützkow KB; Olsen AK; Duale N
    PLoS One; 2020; 15(4):e0231040. PubMed ID: 32240265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations.
    Glinge C; Clauss S; Boddum K; Jabbari R; Jabbari J; Risgaard B; Tomsits P; Hildebrand B; Kääb S; Wakili R; Jespersen T; Tfelt-Hansen J
    PLoS One; 2017; 12(2):e0167969. PubMed ID: 28151938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the preanalytical variables affecting the measurement of clinically relevant free-circulating microRNAs: focus on sample matrix, platelet depletion, and storage conditions.
    Faraldi M; Sansoni V; Perego S; Gomarasca M; Kortas J; Ziemann E; Banfi G; Lombardi G
    Biochem Med (Zagreb); 2020 Feb; 30(1):010703. PubMed ID: 31839723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of long-term storage and freeze-thawing on eight circulating microRNAs in plasma samples.
    Matias-Garcia PR; Wilson R; Mussack V; Reischl E; Waldenberger M; Gieger C; Anton G; Peters A; Kuehn-Steven A
    PLoS One; 2020; 15(1):e0227648. PubMed ID: 31935258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of the Anticoagulant Type in Blood Collection Tubes on Circulating Extracellular Plasma MicroRNA Profiles Revealed by Small RNA Sequencing.
    Zhelankin AV; Iulmetova LN; Sharova EI
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma processing conditions substantially influence circulating microRNA biomarker levels.
    Cheng HH; Yi HS; Kim Y; Kroh EM; Chien JW; Eaton KD; Goodman MT; Tait JF; Tewari M; Pritchard CC
    PLoS One; 2013; 8(6):e64795. PubMed ID: 23762257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Pre-Analytical Factors on the Analysis of Circulating MicroRNA.
    Shiotsu H; Okada K; Shibuta T; Kobayashi Y; Shirahama S; Kuroki C; Ueda S; Ohkuma M; Ikeda K; Ando Y; Matsui H; Kayamori Y; Umemura T
    Microrna; 2018; 7(3):195-203. PubMed ID: 29984665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical Trials.
    Murray MJ; Watson HL; Ward D; Bailey S; Ferraresso M; Nicholson JC; Gnanapragasam VJ; Thomas B; Scarpini CG; Coleman N
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):208-218. PubMed ID: 29254935
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of Storage Tubes for Combined Analysis of Circulating Nucleic Acids in Liquid Biopsies.
    Ward Gahlawat A; Lenhardt J; Witte T; Keitel D; Kaufhold A; Maass KK; Pajtler KW; Sohn C; Schott S
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide identification of circulating-miRNA expression quantitative trait loci reveals the role of several miRNAs in the regulation of cardiometabolic phenotypes.
    Nikpay M; Beehler K; Valsesia A; Hager J; Harper ME; Dent R; McPherson R
    Cardiovasc Res; 2019 Sep; 115(11):1629-1645. PubMed ID: 30715214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs as novel biomarkers for platelet activation.
    Willeit P; Zampetaki A; Dudek K; Kaudewitz D; King A; Kirkby NS; Crosby-Nwaobi R; Prokopi M; Drozdov I; Langley SR; Sivaprasad S; Markus HS; Mitchell JA; Warner TD; Kiechl S; Mayr M
    Circ Res; 2013 Feb; 112(4):595-600. PubMed ID: 23283721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Circulating MicroRNA Panel for Malignant Germ Cell Tumor Diagnosis and Monitoring.
    Murray MJ; Scarpini CG; Coleman N
    Methods Mol Biol; 2021; 2195():225-243. PubMed ID: 32852767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition and validation of a custom protocol to detect miRNAs in the spent media after blastocyst culture: searching for biomarkers of implantation.
    Cimadomo D; Rienzi L; Giancani A; Alviggi E; Dusi L; Canipari R; Noli L; Ilic D; Khalaf Y; Ubaldi FM; Capalbo A
    Hum Reprod; 2019 Sep; 34(9):1746-1761. PubMed ID: 31419301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preanalytical considerations in quantifying circulating miRNAs that predict end-stage kidney disease in diabetes.
    Satake E; Krolewski B; Kobayashi H; Md Dom ZI; Ricca J; Wilson JM; Hoon DS; Duffin KL; Pezzolesi MG; Krolewski AS
    JCI Insight; 2024 Jun; 9(12):. PubMed ID: 38912578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of circulating microRNA during early gestation in Japanese black cattle.
    Ono K; Okamoto S; Ninomiya C; Toji N; Kanazawa T; Ishiguro-Oonuma T; Takahashi T; Iga K; Kizaki K
    Domest Anim Endocrinol; 2022 Apr; 79():106706. PubMed ID: 34973621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Individual qPCR Performance Parameters for Quality Control of Circulating MicroRNA Data.
    Brunet-Vega A; Quílez ME; Ramírez-Lázaro MJ; Lario S
    Methods Mol Biol; 2018; 1699():187-199. PubMed ID: 29086378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
    Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
    World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Robust Protocol to Quantify Circulating Cancer Biomarker MicroRNAs.
    Bell E; Watson HL; Bailey S; Murray MJ; Coleman N
    Methods Mol Biol; 2017; 1580():265-279. PubMed ID: 28439839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology.
    Sartorius K; Sartorius B; Kramvis A; Singh E; Turchinovich A; Burwinkel B; Madiba T; Winkler CA
    BMC Cancer; 2017 Dec; 17(1):894. PubMed ID: 29282036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.